Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. 8-K Event Item 7 · Item 9
  2. REGDEX Other REGDEX
  3. SC 13G Stake Amended Statement of Ownership
  4. S-3 Offering Registration Statement
  5. 8-K Event Item 5 · Item 7
  6. 10-Q Report Quarterly Report
  7. 8-K Event Item 7 · Item 9
  8. ARS Other Annual Report to Security Holders
  9. DEF 14A Proxy Proxy Statement
  10. 10-K Report Annual Report
  11. 8-K Event Item 5 · Item 7
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 10-Q Report Quarterly Report
  14. 10-Q Report Quarterly Report
  15. 10-Q Report Quarterly Report
  16. DEF 14A Proxy Proxy Statement
  17. 10-K Report Annual Report
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 60 of 65 · 1,298 filings